A study on the pharmacokinetic bioequivalence of oral tablet formulations of riluzole among healthy volunteers utilizing HPLC-MS/MS
These findings establish the bioequivalence of the 50-mg test preparation of oral riluzole tablets with the reference listed drug.
Authors
- Xuan Zhou (ORCID: https://orcid.org/0000-0003-2522-1283)
- Zheng Liao
- Bingzhen Lin
- Keli Wang
- Rui Wang (ORCID: https://orcid.org/0000-0002-4792-1945)
- Wanggang Zhang (ORCID: https://orcid.org/0009-0007-7413-1563)
- Li Ma (ORCID: https://orcid.org/0000-0002-3914-164X)
- Linghong Chen (ORCID: https://orcid.org/0000-0002-8171-4632)
- Fei Yu (ORCID: https://orcid.org/0000-0003-4367-2707)
Institutions
- China Pharmaceutical University (CN)
- Jiangsu Nhwa Pharmaceutical (China) (CN)
- Zhejiang Hospital (CN)
Publication Details
- Journal
- BMC Pharmacology and Toxicology
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1186/s40360-025-00931-1
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00